John A. DeFord - 21 Jan 2026 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Reporting relationship: Director
Issuer ticker: GMED
Reported as of: 21 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Jan 2026, 16:49:37 UTC
Prior SEC filing: 03 Nov 2025
Next SEC filing: 03 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Kelly G. Huller, Attorney-in-Fact

Key filing fact

John A. DeFord filed Form 4 for GLOBUS MEDICAL INC (GMED) on 23 Jan 2026.

Key facts

This page summarizes John A. DeFord's Form 4 filing for GLOBUS MEDICAL INC (GMED).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 Jan 2026, 16:49.

Change

Previous filing in this sequence was filed on 03 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001403373 Primary reporting owner

DeFord John A

Relationship: Director
Address: VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVE, AUDUBON
Signature: /s/ Kelly G. Huller, Attorney-in-Fact
Signature date: 23 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GMED transaction Derivative

Stock Option (Right to Buy Class A Common Stock)

Award

Transaction value: $0
Shares: +15,000
Change %
Price: $0.000000
Shares after: 15,000
Date: 21 Jan 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 15,000
Exercise price: $94.15
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options were granted on January 21, 2026, and will vest on January 1, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .